{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hypercoagulability-syndrome-due-to-glycosylphosphatidylinositol-deficiency","columns":[{"gene":"","key":"population-9253d249eeef4415726c","label":"Glycosylphosphatidylinositol deficiency","mondoId":"MONDO:0012465","onsetQualifier":null,"originColumnKey":"MONDO:0012465/OMIM:610293","originalViews":[{"key":"MONDO:0012465/OMIM:610293","label":"Glycosylphosphatidylinositol deficiency","scopeLabel":"OMIM:610293","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["1ec3af33e1825f2f05de056a66eec6dbf3aa96e6e5e5799fda4e453920d7aa99","21f4d8855cb3f1dcadfa10ef73b22a52e858442606724fca727fec68cdba66ec","25cf9da7e2bd160fdc699af66c2d99c6d6b73de082ad67eb547c00c1361c438c","26bd9b38b8b061ced8335a5d02eedda356735546b3d113bb3337cca50887c010","2b23731d364ffb36508144408becca46eb201618ad6f365542d3368791aef43c","7afd6f808c5334f204afc73479aeb6bcca486cabd4e33908953feb170c3830b7","7db47760f7b188ff5df69547332b9efb7fa2f3533cd670c24b72c780949be80c","a2d02ff215b319d25c5ba8fcd2edd741c49a46cdfff5a172906a18bacf5fa273","d1742f89409d31cc03a8c0b6d96318240d74a2433fe4b051890b69b1b0e1e11f","f27c5370abe786f4cc6b4b5377bf307e6df08b0fa69bedbd108a041e1896a850","f7602e90c98f61a9645ff04d7bceb337bfd6f7bb7364c9ab29bf0b76ae962f07"],"recordQualifiers":{},"scopeLabel":"OMIM:610293","sourceIds":["OMIM:610293"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-9253d249eeef4415726c"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0005561","HP:0010819","HP:0000750","HP:0002121","HP:0030243","HP:0002240","HP:0001409"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":8,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":11,"sourceGroups":{"published":11}},"features":[{"hpoId":"HP:0005561","label":"Abnormal bone marrow cell morphology","primary":true},{"hpoId":"HP:0010819","label":"Atonic seizure","primary":true},{"hpoId":"HP:0000750","label":"Delayed speech and language development","primary":true},{"hpoId":"HP:0002121","label":"Generalized non-motor (absence) seizure","primary":true},{"hpoId":"HP:0030243","label":"Hepatic vein thrombosis","primary":true},{"hpoId":"HP:0002240","label":"Hepatomegaly","primary":true},{"hpoId":"HP:0001409","label":"Portal hypertension","primary":true},{"hpoId":"HP:0030242","label":"Portal vein thrombosis","primary":false},{"hpoId":"HP:0031555","label":"Reduced granulocyte CD59 level","primary":false},{"hpoId":"HP:0001744","label":"Splenomegaly","primary":false},{"hpoId":"HP:0004936","label":"Venous thrombosis","primary":false}],"ledeHtml":"A rare congenital disorder of glycosylation characterized by cerebral and portal vein thrombosis, portal hypertension, macrocephaly, and persistent absence seizures. Additional reported features include mild to moderate global developmental delay and intellectual disability, as well as thrombocytopenia. Brain imaging may show variable stages of infarction and cerebral and cerebellar atrophy.","mondoId":"MONDO:0012465","node":{"canonicalSlug":"hypercoagulability-syndrome-due-to-glycosylphosphatidylinositol-deficiency","comparisons":[{"documentSha256":"dd5cdcca2ba0d2ce78eef1eabc66385e8dd2b5c3998ed5de60957060fb6fcef3","key":"legacy-hypercoagulability-syndrome-due-to-glycosylphosphatidylinositol-deficiency","kind":"legacy","label":"hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency","memberIds":["MONDO:0012465"],"mondoId":"MONDO:0012465","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hypercoagulability-syndrome-due-to-glycosylphosphatidylinositol-deficiency.dd5cdcca2ba0d2ce78eef1eabc66385e8dd2b5c3998ed5de60957060fb6fcef3.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency","originalSourceId":"ORPHA:83639","paragraphs":["A rare congenital disorder of glycosylation characterized by cerebral and portal vein thrombosis, portal hypertension, macrocephaly, and persistent absence seizures. Additional reported features include mild to moderate global developmental delay and intellectual disability, as well as thrombocytopenia. Brain imaging may show variable stages of infarction and cerebral and cerebellar atrophy."],"rawAttribution":"MONDO:0012465","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:06:48Z","upstream":"MONDO:0012465","url":"https://rarediseases.info.nih.gov/diseases/9965"},"ownColumnKeys":["population-9253d249eeef4415726c"],"publication":"published","relationships":[{"kind":"parent","label":"congenital hematological disorder","mondoId":"MONDO:0009332","slug":null},{"kind":"parent","label":"inborn disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation","mondoId":"MONDO:0017748","slug":null},{"kind":"parent","label":"inherited blood coagulation disorder","mondoId":"MONDO:0021181","slug":"inherited-blood-coagulation-disorder"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"count","key":"1ec3af33e1825f2f05de056a66eec6dbf3aa96e6e5e5799fda4e453920d7aa99","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:610293","disease_name":"Glycosylphosphatidylinositol deficiency","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0001744","is_excluded":false,"label":"Splenomegaly","onset_id":null,"reference":"PMID:16767100","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"21f4d8855cb3f1dcadfa10ef73b22a52e858442606724fca727fec68cdba66ec","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:610293","disease_name":"Glycosylphosphatidylinositol deficiency","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0030242","is_excluded":false,"label":"Portal vein thrombosis","onset_id":null,"reference":"PMID:16767100","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"25cf9da7e2bd160fdc699af66c2d99c6d6b73de082ad67eb547c00c1361c438c","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:610293","disease_name":"Glycosylphosphatidylinositol deficiency","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0030243","is_excluded":false,"label":"Hepatic vein thrombosis","onset_id":null,"reference":"PMID:16767100","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"26bd9b38b8b061ced8335a5d02eedda356735546b3d113bb3337cca50887c010","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:610293","disease_name":"Glycosylphosphatidylinositol deficiency","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0031555","is_excluded":false,"label":"Reduced granulocyte CD59 level","onset_id":null,"reference":"PMID:17442906","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2b23731d364ffb36508144408becca46eb201618ad6f365542d3368791aef43c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610293","disease_name":"Glycosylphosphatidylinositol deficiency","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0000750","is_excluded":false,"label":"Delayed speech and language development","onset_id":null,"reference":"PMID:16767100","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7afd6f808c5334f204afc73479aeb6bcca486cabd4e33908953feb170c3830b7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610293","disease_name":"Glycosylphosphatidylinositol deficiency","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0002121","is_excluded":false,"label":"Generalized non-motor (absence) seizure","onset_id":null,"reference":"PMID:16767100","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7db47760f7b188ff5df69547332b9efb7fa2f3533cd670c24b72c780949be80c","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:610293","disease_name":"Glycosylphosphatidylinositol deficiency","evidence":"PCS","frequency_raw":"0/3","hpo_id":"HP:0005561","is_excluded":true,"label":"Abnormal bone marrow cell morphology","onset_id":null,"reference":"PMID:16767100","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"a2d02ff215b319d25c5ba8fcd2edd741c49a46cdfff5a172906a18bacf5fa273","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:610293","disease_name":"Glycosylphosphatidylinositol deficiency","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0004936","is_excluded":false,"label":"Venous thrombosis","onset_id":null,"reference":"PMID:16767100","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d1742f89409d31cc03a8c0b6d96318240d74a2433fe4b051890b69b1b0e1e11f","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:610293","disease_name":"Glycosylphosphatidylinositol deficiency","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0001409","is_excluded":false,"label":"Portal hypertension","onset_id":null,"reference":"PMID:16767100","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f27c5370abe786f4cc6b4b5377bf307e6df08b0fa69bedbd108a041e1896a850","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:610293","disease_name":"Glycosylphosphatidylinositol deficiency","evidence":"PCS","frequency_raw":"2/3","hpo_id":"HP:0002240","is_excluded":false,"label":"Hepatomegaly","onset_id":null,"reference":"PMID:16767100","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f7602e90c98f61a9645ff04d7bceb337bfd6f7bb7364c9ab29bf0b76ae962f07","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:610293","disease_name":"Glycosylphosphatidylinositol deficiency","evidence":"PCS","frequency_raw":"1/3","hpo_id":"HP:0010819","is_excluded":false,"label":"Atonic seizure","onset_id":null,"reference":"PMID:16767100","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9965\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012465\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0012465</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare congenital disorder of glycosylation characterized by cerebral and portal vein thrombosis, portal hypertension, macrocephaly, and persistent absence seizures. Additional reported features include mild to moderate global developmental delay and intellectual disability, as well as thrombocytopenia. Brain imaging may show variable stages of infarction and cerebral and cerebellar atrophy.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/9965\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"hypercoagulability-syndrome-due-to-glycosylphosphatidylinositol-deficiency","sourceDocuments":[{"name":"GARD: Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency","reviewed":null,"source_release":"2026-10-21T17:06:48Z","url":"https://rarediseases.info.nih.gov/diseases/9965"},{"name":"MONDO: hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0012465"}],"sourceNote":"","synonyms":["congenital disorder of glycosylation due to PIGM deficiency","GPID","PIGM-CDG"],"takeawayHtml":"","title":"hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency"},"schemaVersion":1}
